S&P 500
(0.03%) 5 088.80 points
Dow J
(0.16%) 39 132 points
Nasdaq
(-0.28%) 15 997 points
Oil
(-2.60%) $76.57
Gas
(-8.66%) $1.582
Gold
(0.74%) $2 045.80
Silver
(0.84%) $22.98
Platinum
(0.11%) $906.50
USD/EUR
(0.04%) $0.924
USD/NOK
(0.33%) $10.53
USD/GBP
(-0.12%) $0.789
USD/RUB
(0.62%) $93.60

Realtime updates for Protagonist Therapeutics [PTGX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
75.00%
return 5.53%
SELL
50.00%
return -0.30%
Last Updated23 Feb 2024 @ 16:00

2.85% $ 28.48

BUY 13423 min ago

@ $27.66

Issued: 14 Feb 2024 @ 13:56


Return: 2.98%


Previous signal: Feb 14 - 09:30


Previous signal: Sell


Return: 0.75 %

Live Chart Being Loaded With Signals

Commentary (23 Feb 2024 @ 16:00):
Profile picture for Protagonist Therapeutics Inc

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases...

Stats
Today's Volume 289 767
Average Volume 813 893
Market Cap 1.64B
EPS $-0.580 ( 2023-11-02 )
Next earnings date ( $-0.160 ) 2024-03-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -10.91
ATR14 $0.0220 (0.08%)
Insider Trading
Date Person Action Amount type
2024-02-15 Patel Dinesh V Ph D Sell 3 717 Common Stock
2024-01-16 Molina Arturo Md Sell 427 Common Stock
2024-01-16 Ali Asif Sell 1 452 Common Stock
2024-01-09 Gupta Suneel Buy 5 000 Common Stock
2024-01-09 Gupta Suneel Sell 5 000 Common Stock
INSIDER POWER
81.09
Last 96 transactions
Buy: 2 962 675 | Sell: 458 765

Volume Correlation

Long: 0.40 (neutral)
Short: -0.13 (neutral)
Signal:(69.67) Neutral

Protagonist Therapeutics Correlation

10 Most Positive Correlations
ITAQU0.969
PLYA0.949
MCAA0.937
BRLI0.932
PANL0.929
IOAC0.927
RNXT0.925
MLTX0.923
RIVE0.923
ALTR0.92
10 Most Negative Correlations
LMPX-0.928
AROW-0.921
JAGX-0.921
ONEM-0.915
PSHG-0.91
RPRX-0.908
GNTY-0.908
BWB-0.907
CSSEP-0.906
BLUE-0.901

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Protagonist Therapeutics Correlation - Currency/Commodity

The country flag 0.46
( neutral )
The country flag 0.30
( neutral )
The country flag 0.00
( neutral )
The country flag -0.27
( neutral )
The country flag 0.69
( moderate )
The country flag -0.06
( neutral )

Protagonist Therapeutics Financials

Annual 2022
Revenue: $26.58M
Gross Profit: $26.58M (100.00 %)
EPS: $-2.52
Q3 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.580
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.680
Q1 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.620

Protagonist Therapeutics

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 integrin- specific antagonist peptide that is in Phase II clinical trials for treating inflammatory bowel disease (IBD); and PN-235, an orally delivered interleukin-23 receptor specific antagonist for the treatment of IBD and non-IBD indications. The company has a license and collaboration agreement with Janssen Biotech, Inc. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

AboutLive Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators